Blood pressure and long-term mortality in older patients: results of the Fiesole Misurata Follow-up Study.
Blood pressure
Elderly
Hypertension
Mortality
Journal
Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
13
10
2019
accepted:
12
03
2020
pubmed:
1
4
2020
medline:
26
11
2020
entrez:
1
4
2020
Statut:
ppublish
Résumé
Optimal blood pressure (BP) control can prevent major adverse health events, but target values are still controversial, especially in older patients with comorbidities, frailty and disability. To evaluate mortality according to BP values in a cohort of older adults enrolled in the Fiesole Misurata Study, after a 6-year follow-up. Living status as of December 31, 2016 was obtained in 385 subjects participating in the Fiesole Misurata Study. Patients' characteristics were analysed to detect predictors of mortality. At baseline, all participants had undergone office BP measurement and a comprehensive geriatric assessment. After a 6-year follow-up, 97 participants had died (25.2%). After adjustment for comorbidities and comprehensive geriatric assessment, mortality was significantly lower for SBP 140-159 mmHg as compared with 120-139 mmHg (HR 0.54, 95% CI 0.33-0.89). This result was also confirmed in patients aged 75 + (HR 0.49, 95% CI 0.29-0.85), and in those with disability (HR 0.36, 95% CI 0.15-0.86) or taking antihypertensive medications (HR 0.49, 95% CI 0.28-0.86). An intensive BP control may lead to greater harm than benefit in older adults. Indeed, the European guidelines recommend caution in BP lowering in older patients, especially if functionally compromised, to minimize the risk of hypotension-related adverse events. After a 6-year follow-up, mortality risk was lower in participants with SBP 140-159 mmHg as compared with SBP 120-139 mmHg, in the overall population and in the subgroups of subjects aged 75 + , with a disability or taking anti-hypertensive medications.
Sections du résumé
BACKGROUND
BACKGROUND
Optimal blood pressure (BP) control can prevent major adverse health events, but target values are still controversial, especially in older patients with comorbidities, frailty and disability.
AIMS
OBJECTIVE
To evaluate mortality according to BP values in a cohort of older adults enrolled in the Fiesole Misurata Study, after a 6-year follow-up.
METHODS
METHODS
Living status as of December 31, 2016 was obtained in 385 subjects participating in the Fiesole Misurata Study. Patients' characteristics were analysed to detect predictors of mortality. At baseline, all participants had undergone office BP measurement and a comprehensive geriatric assessment.
RESULTS
RESULTS
After a 6-year follow-up, 97 participants had died (25.2%). After adjustment for comorbidities and comprehensive geriatric assessment, mortality was significantly lower for SBP 140-159 mmHg as compared with 120-139 mmHg (HR 0.54, 95% CI 0.33-0.89). This result was also confirmed in patients aged 75 + (HR 0.49, 95% CI 0.29-0.85), and in those with disability (HR 0.36, 95% CI 0.15-0.86) or taking antihypertensive medications (HR 0.49, 95% CI 0.28-0.86).
DISCUSSION
CONCLUSIONS
An intensive BP control may lead to greater harm than benefit in older adults. Indeed, the European guidelines recommend caution in BP lowering in older patients, especially if functionally compromised, to minimize the risk of hypotension-related adverse events.
CONCLUSIONS
CONCLUSIONS
After a 6-year follow-up, mortality risk was lower in participants with SBP 140-159 mmHg as compared with SBP 120-139 mmHg, in the overall population and in the subgroups of subjects aged 75 + , with a disability or taking anti-hypertensive medications.
Identifiants
pubmed: 32227283
doi: 10.1007/s40520-020-01534-y
pii: 10.1007/s40520-020-01534-y
doi:
Substances chimiques
Antihypertensive Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2057-2064Références
Lim SS, Vos T, Flaxman AD et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2224–2260
doi: 10.1016/S0140-6736(12)61766-8
Beckett NS, Peters R, Fletcher AE, HYVET Study et al (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358:1887–1898
doi: 10.1056/NEJMoa0801369
The SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK et al (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:2103–2116
doi: 10.1056/NEJMoa1511939
Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM et al (2016) Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 315:2673–2682
doi: 10.1001/jama.2016.7050
The ACCORD Study Group, Cushman WC, Evans GW, Byington RP et al (2010) Effects of intensive blood-pressure control in Type 2 diabetes mellitus. N Engl J Med 362:1575–1585
doi: 10.1056/NEJMoa1001286
Mancia G, Kjeldsen SE, Zappe DH et al (2016) Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial. Eur Heart J 37:955–964
doi: 10.1093/eurheartj/ehv633
Tanna MS, Bangalore S (2015) Antihypertensive therapy and the J-curve: fact or fiction? Curr Hypertens Rep 17:6
doi: 10.1007/s11906-014-0516-y
Ogliari G, Westendorp RG, Muller M et al (2015) Blood pressure and 10-year mortality risk in the Milan Geriatrics 75+ cohort study: role of functional and cognitive status. Age Ageing 44:932–937
doi: 10.1093/ageing/afv141
Ritchie LD, Campbell NC, Murchie P (2011) New NICE guidelines for hypertension. BMJ 343:d5644
doi: 10.1136/bmj.d5644
Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219
doi: 10.1093/eurheartj/eht151
James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:507–520
doi: 10.1001/jama.2013.284427
Weber MA, Schiffrin EL, White WB et al (2014) Clinical practice guidelines for the management of hypertension in the community: statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) 16:14–26
doi: 10.1111/jch.12237
Lapi F, Lucenteforte E, Moschini M et al (2013) Representativeness of the "Fiesole Misurata" study database for use in pharmaco-epidemiological investigations on adherence to antihypertensive medications. Aging Clin Exp Res 25:433–445
doi: 10.1007/s40520-013-0060-7
Brignole M, Moya A, de Lange FJ et al (2018) 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 39:1883–1948
doi: 10.1093/eurheartj/ehy037
Staessen JA, Fagard R, Thijs L et al (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350:757–764
doi: 10.1016/S0140-6736(97)05381-6
Benetos A, Bulpitt CJ, Petrovic M et al (2016) An expert opinion from the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old Frail Subjects. Hypertension 67:820–825
doi: 10.1161/HYPERTENSIONAHA.115.07020
Mancia G, Kjeldsen SE (2017) Adopting Systolic Pressure Intervention Trial (SPRINT)-like office blood pressure measurements in clinical practice. J Hypertens 35:471–472
doi: 10.1097/HJH.0000000000001229
Paini A, Bertacchini F, Stassaldi D et al (2018) Unattended versus attended blood pressure measurement: mean values and determinants of the difference. Int J Cardiol S0167–5273:30951–30953
Russo G, Liguori I, Aran L et al (2018) Impact of SPRINT results on hypertension guidelines: implications for "frail" elderly patients. J Hum Hypertens 32:633–638
doi: 10.1038/s41371-018-0086-6
Mossello E, Pieraccioli M, Nesti N et al (2015) Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med 175:578–585
doi: 10.1001/jamainternmed.2014.8164
Zhang XE, Cheng B, Wang Q (2016) Relationship between high blood pressure and cardiovascular outcomes in elderly frail patients: a systematic review and meta-analysis. Geriatr Nurs 37:385–392
doi: 10.1016/j.gerinurse.2016.05.006
Benetos A, Labat C, Rossignol P et al (2015) Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study. JAMA Intern Med 175:989–995
doi: 10.1001/jamainternmed.2014.8012
Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71:e13–e115
Ioannidis JA (2018) Diagnosis and treatment of hypertension in the 2017 ACC/AHA guidelines and in the real world. JAMA 319:115–116
doi: 10.1001/jama.2017.19672
Bakris G, Sorrentino M (2018) Redefining hypertension—assessing the new blood-pressure guidelines. N Engl J Med 378:497–499
doi: 10.1056/NEJMp1716193
Williams B, Mancia G, Spiering W et al (2018) 2018 ESC/ESH guidelines for the management of arterial hypertension: the Task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Eur Heart J 39:3021–3104
doi: 10.1093/eurheartj/ehy339
Sexton DJ, Canney M, O'Connell MDL et al (2017) Injurious falls and syncope in older community-dwelling adults meeting inclusion criteria for SPRINT. JAMA Intern Med 177:1385–1387
doi: 10.1001/jamainternmed.2017.2924
Mancia G, Corrao G (2018) Global impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: a prospective from Italy. Circulation 137:889–890
doi: 10.1161/CIRCULATIONAHA.117.032850
Cao DX, Tran RJC (2018) Considerations for optimal blood pressure goals in the elderly pupulation: a review of emergent evidence. Pharmacotherapy 38:370–381
doi: 10.1002/phar.2081
Ungar A, Pepe G, Lambertucci L et al (2009) Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension. J Am Geriatr Soc 57:291–296
doi: 10.1111/j.1532-5415.2008.02123.x
Waits GS, O'Neal WT, Sandesara PB et al (2018) Association between low diastolic blood pressure and subclinical myocardial injury. Clin Res Cardiol 107:312–318
doi: 10.1007/s00392-017-1184-0
Rahman F, Al Rifai M, Blaha MJ et al (2017) Relation of diastolic blood pressure and coronaryartery calcium to coronary events and outcomes (from the multi-ethnic study of atherosclerosis). Am J Cardiol 120:1797–1803
doi: 10.1016/j.amjcard.2017.07.094
Vidal-Petiot E, Greenlaw N, Ford I et al (2018) Relationships between components of blood pressure and cardiovascular events in patients with stable coronary artery disease and hypertension. Hypertension 71:168–176
doi: 10.1161/HYPERTENSIONAHA.117.10204
Kimm H, Mok Y, Lee SJ et al (2018) The J-curve between diastolic blood pressure and risk of all-cause and cardiovascular death. Korean Circ J 48:36–47
doi: 10.4070/kcj.2017.0036
Liguori I, Russo G, Aran L et al (2018) Sarcopenia: assessment of disease burden and strategies to improve outcomes. Clin Interv Aging 13:913–927
doi: 10.2147/CIA.S149232
Wieling W, Krediet CT, Dijk N et al (2007) Initial orthostatic hypotension: review of a forgotten condition. Clin Sci (Lond) 112:157–165
doi: 10.1042/CS20060091
Krediet CT, Go-Schön IK, Kim YS et al (2007) Management of initial orthostatic hypotension: lower body muscle tensing attenuates the transient arterial blood pressure decrease upon standing from squatting. Clin Sci (Lond) 113:401–407
doi: 10.1042/CS20070064